Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).

Abstract

Authors

• Shankar Siva
  Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Center, University of Melbourne, Melbourne, Victoria, Australia.
• Alexander V Louie
  Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.
• Andrew Warner
  Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.
• Alexander Muacevic
  Cyberknife Center, University of Munich Hospitals, Munich, Germany.
• Senthilkumar Gandhidasan
  Department of Radiation Oncology, Illawarra Cancer Care Centre, Wollongong, NSW, Australia.
• Lee Ponsky
  University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio.
• Rodney Ellis
  University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio.
• Irving Kaplan
  Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
• Anand Mahadevan
  Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
• William Chu
  Department of Radiation Oncology, Sunnybrook Health Sciences Centre and the University of Toronto, Toronto, Ontario, Canada.
• Anand Swaminath
  Division of Radiation Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.
• Hiroshi Onishi
  Department of Radiology, University of Yamanashi, Yamanashi, Japan.
• Bin Teh
  Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research Institute, Houston, Texas.
• Rohann J Correa
  Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.
• Simon S Lo
  Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington.
• Michael Staehler
  Cyberknife Center, University of Munich Hospitals, Munich, Germany.

Keywords

External Resources